ArticleFrontiers in bioengineering and biotechnology2026
Generation of alveolar organoids from human induced pluripotent stem cells using a stirred-tank bioreactor.
Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Organoids are increasingly establishing themselves as a valuable, patient- centered alternative to preclinical animal models as they are highly complex models for organ development studies and, in particular, robust disease models for mechanistic investigations and therapy response assessments. Methods: We previously established a very simple and practical protocol for producing induced pluripotent stem cell-derived lung organoids (iPSC-LuOrgs) from pre-differentiated embryoid bodies using a stirred bioreactor system. Here we adapted the protocol to investigate the generation of lung organoids directly from iPSCs in stirred suspension, and performed a comprehensive cellular and molecular characterization, including single-cell RNA sequencing, of the resulting LuOrgs. Results: Direct transfer of iPSCs as a single-cell suspension into the bioreactor and subsequent differentiation led to the formation of lung structures that appeared less differentiated and were predominantly alveolar in nature. Fibroblasts and bronchial epithelial cells were generated only to a limited extent. Discussion: Pre- differentiation of iPSCs, e.g., in embryoid bodies seems to be a necessary prerequisite for the efficient generation of iPSC-LuOrgs, which then exhibit alveolar and bronchial cell types and structures supported by mesenchymal cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.